NCT07732764

Brief Summary

This randomized, double-blind, sham-controlled study aims to evaluate the effects of transcutaneous electrical nerve stimulation (TENS) on acute postoperative pain, sleep quality, and quality of life in patients undergoing video-assisted thoracoscopic surgery (VATS). Participants will be randomly assigned to either an active TENS group or a sham TENS group. TENS treatment will be administered twice daily for 30 minutes over three consecutive days beginning 24 hours after surgery. Pain intensity, sleep quality, and quality of life will be assessed at predefined time points to determine the effectiveness of TENS as an adjunctive postoperative pain management strategy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Aug 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress85%
Aug 2025Oct 2026

Study Start

First participant enrolled

August 28, 2025

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

July 17, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 29, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2026

Last Updated

July 29, 2026

Status Verified

July 1, 2026

Enrollment Period

1.1 years

First QC Date

July 17, 2026

Last Update Submit

July 26, 2026

Conditions

Keywords

Sleep QualityQuality of LifeVideo-Assisted Thoracoscopic Surgery (VATS)Transcutaneous Electrical Nerve Stimulation (TENS)Acute Postoperative Pain

Outcome Measures

Primary Outcomes (1)

  • Pain intensity (Numeric Rating Scale, NRS)

    Pain intensity will be assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.

    Preoperative baseline; 24 hours after initiation of the intervention; 72 hours after initiation of the intervention; and on the day of hospital discharge.

Secondary Outcomes (2)

  • Sleep quality (Richards-Campbell Sleep Questionnaire, RCSQ)

    Preoperative baseline; 24 hours after initiation of the intervention; 72 hours after initiation of the intervention; and on the day of hospital discharge.

  • Health-related quality of life (PROMIS Global Health Scale)

    Preoperative baseline; 24 hours after initiation of the intervention; 72 hours after initiation of the intervention; and on the day of hospital discharge.

Study Arms (2)

Active TENS

EXPERIMENTAL

Participants receive active transcutaneous electrical nerve stimulation (TENS) in addition to standard postoperative care. TENS is applied around the surgical site using four electrodes at 100 Hz and a pulse width of 200 microseconds for 30 minutes twice daily for three consecutive days.

Device: Active TENS

Sham TENS

SHAM COMPARATOR

Participants receive sham transcutaneous electrical nerve stimulation (TENS) using identical electrode placement and treatment procedures as the active TENS group, but without therapeutic electrical stimulation. Sessions last 30 minutes twice daily for three consecutive days

Device: Sham TENS

Interventions

Active transcutaneous electrical nerve stimulation (TENS) is administered in addition to standard postoperative care. Four electrodes are placed around the surgical site. Electrical stimulation is delivered at a frequency of 100 Hz with a pulse width of 200 microseconds for 30 minutes per session, twice daily for three consecutive days. The stimulation intensity is adjusted to the highest level tolerated without discomfort.

Active TENS
Sham TENSDEVICE

Sham transcutaneous electrical nerve stimulation (TENS) uses identical electrode placement and treatment procedures as the active TENS intervention but delivers no therapeutic electrical stimulation. Participants continue to receive standard postoperative care.

Sham TENS

Eligibility Criteria

Age15 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 15 to 85 years.
  • Participants younger than 18 years of age must have written informed consent provided by a parent or legal guardian.
  • Able to communicate and read/write in Chinese.
  • Scheduled to undergo video-assisted thoracoscopic surgery (VATS) as determined by the treating physician.
  • Have stable vital signs.
  • Willing to participate in the study and able to complete all study procedures.

You may not qualify if:

  • History of a bleeding disorder.
  • Patients undergoing emergency surgery.
  • Patients undergoing bilateral video-assisted thoracoscopic surgery (VATS).
  • History of cardiac disease, including cardiac arrhythmia or implantation of a cardiac pacemaker.
  • Known allergy or hypersensitivity to TENS electrodes or adhesive pads.
  • Cognitive impairment or inability to comply with the study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yuan's General Hospital

Kaohsiung City, Kaohsiung City, 806, Taiwan

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativeSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Hui-Fang Yeh, phD

    Fooyin University

    STUDY CHAIR
  • JIA-XIN LIN, NP

    Fooyin University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Participants and outcome assessors are blinded to treatment assignment. Participants in the sham TENS group receive identical electrode placement and procedures without therapeutic electrical stimulation to maintain blinding.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants are randomly assigned to either an active TENS group or a sham TENS group in a parallel-group design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 17, 2026

First Posted

July 29, 2026

Study Start

August 28, 2025

Primary Completion (Estimated)

October 1, 2026

Study Completion (Estimated)

October 1, 2026

Last Updated

July 29, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) collected during this study will not be made publicly available. There is no current plan to share de-identified individual participant data with other researchers.

Locations